Literature DB >> 11972291

GLP-1 as a satiety factor in children with eating disorders.

P J Tomasik1, K Sztefko, A Malek.   

Abstract

GLP-1, with its insulinotropic properties and direct action on satiety center in the brain, may be the main hormone regulating the amount of ingested food. In this study, GLP-1 secretion was investigated in age-matched adolescent girls (14 +/- 2 years): 13 with anorexia nervosa (BMI 14.8 +/- 1.4 kg/m(2)), 13 with simple obesity (BMI 33.0 +/- 3.3 kg/m(2)) and 10 healthy girls as a control group (BMI 21.6 +/- 0.7 kg/m(2)). Each girl was subjected to OGTT and standard meal tests after a 12 h overnight fast. Blood samples were collected before and 15, 30, 60, and 120 min after the stimulation. The mean fasted GLP-1 levels in simple obesity group (1.6 +/- 0.3 pmol/l) and in anorexia nervosa group (1.7 +/- 0.3 pmol/l) were significantly lower than those in the control group (2.6 +/- 0.4 pmol/l) (p < 0.05 in both cases). The highest peak concentration of GLP-1 was observed in the control group after both stimuli. In each group, the mean integrated GLP-1 outputs were almost twice as high after OGTT than after the test meal (p < 0.001 in each case). In our opinion, low secretion of GLP-1 in girls with simple obesity may seriously and negatively influence the course of this disease. On the other hand, low GLP-1 levels in girls with anorexia nervosa are beneficial and promote appetite.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11972291     DOI: 10.1055/s-2002-20519

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  16 in total

1.  Characterization of the diurnal rhythm of peptide YY and its association with energy balance parameters in normal-weight premenopausal women.

Authors:  Brenna R Hill; Mary Jane De Souza; Nancy I Williams
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-24       Impact factor: 4.310

Review 2.  Examining weight suppression as a transdiagnostic factor influencing illness trajectory in bulimic eating disorders.

Authors:  Pamela K Keel; Lindsay P Bodell; K Jean Forney; Jonathan Appelbaum; Diana Williams
Journal:  Physiol Behav       Date:  2019-05-30

Review 3.  Endocrine consequences of anorexia nervosa.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Lancet Diabetes Endocrinol       Date:  2014-04-02       Impact factor: 32.069

4.  Interaction of GLP-1 and Ghrelin on Glucose Tolerance in Healthy Humans.

Authors:  Laura C Page; Amalia Gastaldelli; Sarah M Gray; David A D'Alessio; Jenny Tong
Journal:  Diabetes       Date:  2018-07-31       Impact factor: 9.461

5.  Initial evidence that GLP-1 receptor blockade fails to suppress postprandial satiety or promote food intake in humans.

Authors:  Susan J Melhorn; Vidhi Tyagi; Anne Smeraglio; Christian L Roth; Ellen A Schur
Journal:  Appetite       Date:  2014-07-15       Impact factor: 3.868

Review 6.  Role of ghrelin in the pathophysiology of eating disorders: implications for pharmacotherapy.

Authors:  Sebastian Cardona Cano; Myrte Merkestein; Karolina P Skibicka; Suzanne L Dickson; Roger A H Adan
Journal:  CNS Drugs       Date:  2012-04-01       Impact factor: 5.749

7.  Binge-like palatable food intake in rats reduces preproglucagon in the nucleus tractus solitarius.

Authors:  Ashmita Mukherjee; Avery Hum; Tyler J Gustafson; Elizabeth G Mietlicki-Baase
Journal:  Physiol Behav       Date:  2020-02-13

8.  Chronic high-fat feeding increases GIP and GLP-1 secretion without altering body weight.

Authors:  Fei Wang; Stephanie M Yoder; Qing Yang; Alison B Kohan; Tammy L Kindel; Jacob Wang; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-09-03       Impact factor: 4.052

9.  Gut hormone activity of children born to women with and without gestational diabetes.

Authors:  P C Chandler-Laney; N C Bush; D J Rouse; M S Mancuso; B A Gower
Journal:  Pediatr Obes       Date:  2013-01-31       Impact factor: 4.000

Review 10.  Endocrinology of anorexia nervosa in young people: recent insights.

Authors:  Vibha Singhal; Madhusmita Misra; Anne Klibanski
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-02       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.